Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study-Reference-Cited by-同舟云学术

Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective study

Published:2016-07-07 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

De Nunzio Cosimo,Simone Giuseppe,Brassetti Aldo,Mastroianni Riccardo,Collura Devis,Muto Giovanni,Gallucci Michele,Tubaro Andrea

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2442-7

Reference36 articles.

1. De Nunzio C, Freedland SJ, Miano R, Trucchi A, Cantiani A, Carluccini A, et al. Metabolic syndrome is associated with high grade gleason score when prostate cancer is diagnosed on biopsy. Prostate. 2011;71:1492–8. doi: 10.1002/pros.21364 .

2. Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Parretta E, et al. Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest. 2013;36:132–9. doi: 10.1007/BF03346748 .

3. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–607.

4. Ozbek E, Otunctemur A, Dursun M, Sahin S, Koklu I, Erkoc M, et al. The Metabolic Syndrome is Associated with More Aggressive Prostate Cancer. Asian Pac J Cancer Prev. 2014;15:4029–32.

5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic syndrome is associated with PSA biochemical recurrence after radical prostatectomy: a prospective study with a minimum 5-year follow-up;2024-06-27

2. Associations between “Cancer Risk”, “Inflammation” and “Metabolic Syndrome”: A Scoping Review;Biology;2024-05-16

3. From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist’s Dual Role in Prostate Cancer;Cancers;2024-04-18

4. The Impact of Physical Activity on the Outcomes of Active Surveillance in Prostate Cancer Patients: A Scoping Review;Cancers;2024-02-01

5. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study;BMC Urology;2023-09-22